Page last updated: 2024-10-26

brl 42810 and Hepatitis A

brl 42810 has been researched along with Hepatitis A in 1 studies

Hepatitis A: INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water.

Research Excerpts

ExcerptRelevanceReference
"Lamivudine 3 mg/kg was administered on a compassionate-use basis for 14-36 months."1.31Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children. ( Bar-Nathan, N; Ben-Ari, Z; Dinari, G; Mor, E; Shapira, R; Sokal, EM; Tur-Kaspa, R, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shapira, R1
Mor, E1
Bar-Nathan, N1
Sokal, EM1
Tur-Kaspa, R1
Dinari, G1
Ben-Ari, Z1

Other Studies

1 other study available for brl 42810 and Hepatitis A

ArticleYear
Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
    Transplantation, 2001, Jul-27, Volume: 72, Issue:2

    Topics: 2-Aminopurine; Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Cystic F

2001